Vironix Health· news · 1 min read
AI Can Spot Patients At-Risk For CKD Earlier and More Accurately
 (2).DtQlJPUO.png)
💡 Did you know that subtle patterns in routine lab results can predict kidney disease years before serious symptoms appear?
Not all remote patient monitoring (RPM) platforms are created equal, and at Vironix, we back ours with real clinical research and peer-reviewed studies.
Our latest study, “Integrated Machine Learning and Survival Analysis Modeling for Enhanced Chronic Kidney Disease Risk Stratification” (source linked below), shows how we can spot patients at risk for chronic kidney disease earlier and more accurately.
💡 Why this matters:
- Science-backed: Our methods aren’t just ideas — they’re published in a peer-reviewed study.
- Smarter insights for clinicians: By combining data from multiple sources, we help doctors make better decisions sooner.
- Better patient care: Early detection means patients get the right care faster, lowering the risk of serious complications.
While other RPM platforms just collect data, Vironix turns data into actionable insights that make a real difference for patients and clinicians alike.
📞 Interested in bringing Vironix to your practice? We can get you up and running in less than 4 weeks. Email the CEO directly at sswami@vironix.ai to have a conversation and see how our platform can enhance patient care at your clinic.